CAS: 749931-20-2; 4-Bromo-2-Fluoro-5-Methoxybenzaldehyde

该化合物是一种有机化合物,其特点是芳香结构,包括一个苯环,由各种功能组取代; 苯环上存在溴原子,氟氨原子和甲氧基(EurosH3),会影响其化学反应和物理特性; 该化合物通常表现出一种独特的芳香味,是苯丁二烯衍生物的特征; 它在室内温度下,可能没有色色色,黄色液体在有机溶剂中可能具有中等溶性,但由于其防水性,在水溶性而较少溶于水. 卤素分成分的存在可增强其在电益替代反应中的再活动性. 此外, 甲氧基组可以作为一个电饱和组,影响化合物的再活性和稳定性. 与许多苯丁二烯衍生物一样,它可能被用于有机合成,相调和可能具有中度,而有机溶剂的溶性,但因其溶剂的溶解性较不易溶性,同时处理其具体的生物活动,应视其具体的防范性.

结构式图片

欧盟法规

C&L通报

上下游产品

2-氟-5-甲氧基苯甲醛 2-Fluoro-5-Methoxybenzaldehyde 105728-90-3
2-溴-4-氟苯甲醚 2-Bromo-4-Fluoro-1-Methoxybenzene 452-08-4

合成工艺路线路线简述

    📜2-氟-5-甲氧基苯甲醛置于溴体系中,用 氯仿 作为反应溶剂,化学反应 120.0H,以60%的收率获得产物4-溴-2-氟-5-甲氧基苯甲醛
    参考文献: Inhibitors Of Hepatitis C Virus Rna-Dependent Rna Polymerase,And Compositions And Treatments Using The Same[fr] Inhibiteurs De Polymerase D'Arn Dependant D'Arn Du Virus De L'Hepatite C Et Compositions Et Traitement Utilisant Ces Inhibiteurs
    标题: Inhibitors Of Hepatitis C Virus Rna-Dependent Rna Polymerase,And Compositions And Treatments Using The Same[fr] Inhibiteurs De Polymerase D'Arn Dependant D'Arn Du Virus De L'Hepatite C Et Compositions Et Traitement Utilisant Ces Inhibiteurs
    摘要:本发明提供了公式(4)的化合物,以及它们的药学上可接受的盐和溶剂化合物,这些化合物可用作肝炎病毒(hcv)聚合酶酶的抑制剂,并且也可用于治疗hcv感染的hcv感染的哺乳动物.本发明还提供了包含公式(4)的化合物,其药学上可接受的盐和溶剂的药物组合物.此外,本发明提供了制备公式(4)化合物的中间体化合物和方法.

    海关参考信息

    专利信息


    专利号:US-10793557-B2
    优先权日:2018-04-03
    标题 :Sting agonist compounds
    发明人:ALTMAN MICHAEL D; CASH BRANDON D; CHILDERS MATTHEW LLOYD; CUMMING JARED N; DEMONG DUANE E; HAIDLE ANDREW MARC; HENDERSON TIMOTHY J; JEWELL JAMES P; LARSEN MATTHEW A; LIM JONGWON; LU MIN; OTTE RYAN D; TROTTER BENJAMIN WESLEY
    权利人:MERCK SHARP & DOHME
    摘要:Compounds of general formula (I), of general formula (II), of general formula (III), of general formula (IV), of general formula (V), of general formula (VI), and their pharmaceutically acceptable salts, wherein all variables are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are compositions comprising such compounds, processes for the synthesis of such compounds, and to uses of such compounds, including administration of such compounds to induce immune response, to induce STING-dependent type I interferon production, and/or to treat a cell proliferation disorder, such as cancer.

    专利号:US-10730849-B2
    优先权日:2016-10-04
    标 题:Benzo[b]thiophene compounds as STING agonists
    发明人:ALTMAN MICHAEL D; CASH BRANDON D; CHANG WONSUK; CUMMING JARED N; HAIDLE ANDREW M; HENDERSON TIMOTHY J; JEWELL JAMES P; LARSEN MATTHEW A; LIANG RUI; LIM JONGWON; LU MIN; OTTE RYAN D; SIU TONY; TROTTER BENJAMIN WESLEY; TYAGARAJAN SRIRAM
    权利人:MERCK SHARP & DOHME
    摘要:Compounds of general formula (Ia), compounds of general formula (Ia′), compounds of general formula (Ib), compounds of general formula (Ib′), compounds of general formula (I), compounds of general formula (I′), and their pharmaceutically acceptable salts, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 8 , R 9 , X 1 , X 2 , and X 3 are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are processes for the synthesis and use of compounds of the disclosure.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知